In this study, scRNA-seq analysis was performed to investigate the transcriptomic features of TMEM173 in high-risk B-ALL patients, which profiled the differential expression of TMEM173 in BM cells. Here, STING1 is linked to precursor B-cell acute lymphoblastic leukemia.